Primary care providers' use of pharmacist support for delivery of pharmacogenetic testing. - PubMed - NCBI
Pharmacogenomics. 2017 Mar;18(4):359-367. doi: 10.2217/pgs-2016-0177. Epub 2017 Feb 22.
Primary care providers' use of pharmacist support for delivery of pharmacogenetic testing.
Abstract
AIM:
To investigate provider utilization of pharmacist support in the delivery of pharmacogenetic testing in a primary care setting. METHODS:
Two primary care clinics within Duke University Health System participated in the study between December 2012 and July 2013. One clinic was provided with an in-house pharmacist and the second clinic had an on-call pharmacist. RESULTS:
Providers in the in-house pharmacist arm consulted with the pharmacist for 13 of 15 cases, or about one of every four patients tested compared with one of every 7.5 patients in the on-call pharmacist arm. A total of 63 tests were ordered, 48 by providers in the pharmacist-in-house arm. CONCLUSION:
These findings suggest that the availability of an in-house pharmacist increases the likelihood of pharmacogenetic test utilization. KEYWORDS:
delivery model; education; pharmacist consultation; pharmacogenetic testing
.png)
No hay comentarios:
Publicar un comentario